Serum Interleukin-6 is Not Linked with Sleep-Quality, Restless Legs Syndrome, and Depression, But with 6-Month Survival in Hematological Malignancies
- PMID: 30765978
- PMCID: PMC6338000
- DOI: 10.4103/jnrp.jnrp_159_18
Serum Interleukin-6 is Not Linked with Sleep-Quality, Restless Legs Syndrome, and Depression, But with 6-Month Survival in Hematological Malignancies
Abstract
Background: Serum interleukin (IL)-6 has been found to be associated with sleep quality, mood, and survival in patients with solid tumors. Results in these studies were confounded by knowledge of diagnosis to study subjects. Moreover, such data among subjects with hematological malignancies and data regarding restless legs syndrome is limited. The present study was, therefore, conducted to assess the sleep quality, depression, and restless leg syndrome in hematological malignancies and to study if there is any role of IL6 associated with it.
Methods: Sixty-six subjects having hematological malignancy were included in this study after excluding the potential confounders. Sleep quality was examined using Pittsburg Sleep Quality Index, depression by the Patient Health Questionnaire-9. Diagnosis of RLS was made through clinical examination. Serum for measurement of IL-6 was collected at baseline and after 1 month of initiation of chemotherapy. Patients were followed up for 6 months.
Results: Average age of study subjects was 50.16 years with male predominance. Nearly 22.7% had clinical depression, 28.8% had poor quality sleep, and restless legs syndrome (RLS) was reported in 6.1% cases. Nearly 22.7% patients died at 6 months. Disturbed sleep at baseline was associated with depression (odds ratio [OR] =7.89) and poor 6 months survival. Serum IL-6 did not show any association with sleep quality, restless-legs-syndrome, and depression. However, baseline high level of serum IL-6 (OR = 26.06) and low level after chemotherapy (OR = 0.03) were associated with poor survival at 6 months.
Conclusion: Poor quality sleep, depression, and RLS are prevalent among adult subjects with hematological malignancies. Sleep disturbance, high pretreatment inflammatory and lowering of inflammatory load after chemotherapy increase likelihood for poor prognosis. Serum IL-6 did not show any association with sleep quality, restless legs syndrome and depression.
Keywords: Hematological malignancy; inflammation; interleukin-6; prognosis; restless leg syndrome; sleep.
Conflict of interest statement
There are no conflicts of interest.
Similar articles
-
Prevalence of RLS among subjects with chronic liver disease and its effect on sleep and mood.Sleep Med. 2020 Sep;73:144-152. doi: 10.1016/j.sleep.2020.05.036. Epub 2020 Jun 4. Sleep Med. 2020. PMID: 32829189
-
Prevalence and correlates of poor sleep quality in chronic liver disease patients.Sleep Sci. 2021 Jul-Sep;14(3):266-272. doi: 10.5935/1984-0063.20200060. Sleep Sci. 2021. PMID: 35186205 Free PMC article.
-
Restless legs syndrome as a cause of sleep disturbances in cancer patients receiving chemotherapy.J Pain Symptom Manage. 2013 Jul;46(1):56-64. doi: 10.1016/j.jpainsymman.2012.06.018. Epub 2012 Oct 30. J Pain Symptom Manage. 2013. PMID: 23116590
-
Restless legs syndrome in end-stage renal disease.Sleep Med. 2004 May;5(3):309-15. doi: 10.1016/j.sleep.2004.01.014. Sleep Med. 2004. PMID: 15165541 Review.
-
Complementary and alternative therapies for restless legs syndrome: An evidence-based systematic review.Sleep Med Rev. 2018 Apr;38:158-167. doi: 10.1016/j.smrv.2017.06.003. Epub 2017 Jun 19. Sleep Med Rev. 2018. PMID: 28886918 Review.
Cited by
-
LAG3/CD4 Genes Variants and the Risk for Restless Legs Syndrome.Int J Mol Sci. 2022 Nov 26;23(23):14795. doi: 10.3390/ijms232314795. Int J Mol Sci. 2022. PMID: 36499121 Free PMC article.
-
Sleep During Oncological Treatment - A Systematic Review and Meta-Analysis of Associations With Treatment Response, Time to Progression and Survival.Front Neurosci. 2022 Apr 19;16:817837. doi: 10.3389/fnins.2022.817837. eCollection 2022. Front Neurosci. 2022. PMID: 35516799 Free PMC article.
References
-
- Sharma N, Hansen CH, O’Connor M, Thekkumpurath P, Walker J, Kleiboer A, et al. Sleep problems in cancer patients: Prevalence and association with distress and pain. Psychooncology. 2012;21:1003–9. - PubMed
-
- Gibbins J, McCoubrie R, Kendrick AH, Senior-Smith G, Davies AN, Hanks GW. Sleep-wake disturbances in patients with advanced cancer and their family carers. J Pain Symptom Manage. 2009;38:860–70. - PubMed
-
- O’Donnell JF. Insomnia in cancer patients. Clin Cornerstone. 2004;6(Suppl 1D):S6–14. - PubMed
LinkOut - more resources
Full Text Sources